Patient-reported Outcomes of Transperineal Reanastomosis for Recurrent or Obliterative Post-prostatectomy Vesicourethral Anastomotic Stenosis.

PURPOSE: Post-prostatectomy vesicourethral anastomotic stenosis (VUAS) affects up to 5% of patients. A subset of cases remains refractory to endoscopic treatment, significantly impacting quality of life in the long-term. This study presents 15-year follow-up data on patients undergoing open reanastomosis for refractory or obliterative VUAS. PATIENTS AND METHODS: We included patients who underwent transperineal vesicourethral reanastomosis from 2009-2023. The procedure was often staged, with artificial urinary sphincter (AUS) implantation three months later. Co-primary endpoints included retreatment-free survival (RFS) and patient-reported outcome measures (PROMs). RFS was analyzed with Kaplan-Meier estimators, and PROMs were evaluated per scoring manuals. Additionally, we conducted a scoping review of all studies reporting outcomes following complex VUAS reconstruction. RESULTS: Among 46 patients with VUAS, prior endoscopic interventions included dilation (17%), incision (61%), and resection (80%). Median time from prostatectomy to reanastomosis was 23 months (IQR 16-42). At a median follow-up of 80 months (IQR 41-149), RFS rates were 91% at two years and 88% at five years. 30 patients (65%) required staged AUS implantation for stress urinary incontinence. PROMs, assessed in 28 patients (61%), indicated restored voiding function, absence of fecal incontinence, high treatment satisfaction, and low decision regret. Limitations include the absence of preoperative PROMs for baseline comparisons. The scoping review revealed varying success rates ranging from 60% to 92% and a significant underuse of validated PROMs. CONCLUSIONS: Transperineal reanastomosis offers an effective and lasting solution for treating recurrent or obliterative VUAS, with encouraging long-term results and favorable patient-reported outcomes, underscoring its critical role in salvage posterior urethral reconstruction after prostatectomy.

Authors

Institutions

Publication Details

Journal
PubMed
Published
2026-07-16
DOI
https://doi.org/10.1590/s1677-5538.ibju.2026.0112
Primary Topic
Prostate Cancer Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-reported Outcomes of Transperineal Reanastomosis for Recurrent or Obliterative Post-prostatectomy Vesicourethral Anastomotic Stenosis.

Roland Dahlem, Tim A. Ludwig, Navid Roessler, Victor M. Schuettfort et al.
PubMed
Prostate Cancer Diagnosis and Treatment
article

Patient-reported Outcomes of Transperineal Reanastomosis for Recurrent or Obliterative Post-prostatectomy Vesicourethral Anastomotic Stenosis.

Roland Dahlem, Tim A. Ludwig, Navid Roessler, Victor M. Schuettfort, Katharina Oberneder, Max C Wagner, Malte W Vetterlein, Margit Fisch, Robert J Schulz, Jakob Klemm
article en

Abstract

PURPOSE: Post-prostatectomy vesicourethral anastomotic stenosis (VUAS) affects up to 5% of patients. A subset of cases remains refractory to endoscopic treatment, significantly impacting quality of life in the long-term. This study presents 15-year follow-up data on patients undergoing open reanastomosis for refractory or obliterative VUAS. PATIENTS AND METHODS: We included patients who underwent transperineal vesicourethral reanastomosis from 2009-2023. The procedure was often staged, with artificial urinary sphincter (AUS) implantation three months later. Co-primary endpoints included retreatment-free survival (RFS) and patient-reported outcome measures (PROMs). RFS was analyzed with Kaplan-Meier estimators, and PROMs were evaluated per scoring manuals. Additionally, we conducted a scoping review of all studies reporting outcomes following complex VUAS reconstruction. RESULTS: Among 46 patients with VUAS, prior endoscopic interventions included dilation (17%), incision (61%), and resection (80%). Median time from prostatectomy to reanastomosis was 23 months (IQR 16-42). At a median follow-up of 80 months (IQR 41-149), RFS rates were 91% at two years and 88% at five years. 30 patients (65%) required staged AUS implantation for stress urinary incontinence. PROMs, assessed in 28 patients (61%), indicated restored voiding function, absence of fecal incontinence, high treatment satisfaction, and low decision regret. Limitations include the absence of preoperative PROMs for baseline comparisons. The scoping review revealed varying success rates ranging from 60% to 92% and a significant underuse of validated PROMs. CONCLUSIONS: Transperineal reanastomosis offers an effective and lasting solution for treating recurrent or obliterative VUAS, with encouraging long-term results and favorable patient-reported outcomes, underscoring its critical role in salvage posterior urethral reconstruction after prostatectomy.

PubMedVol. 52(4)
Universität Hamburg (DE), Comprehensive Cancer Center Vienna (AT), University Medical Center Hamburg-Eppendorf (DE), Medical University of Vienna (AT)
Peace, Justice and strong institutions
Openalex Percentile: Top 46%
Prostate Cancer Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.